{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T10:39:53Z","timestamp":1767868793407,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,1,17]],"date-time":"2007-01-17T00:00:00Z","timestamp":1168992000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1007\/s11606-006-0023-1","type":"journal-article","created":{"date-parts":[[2007,1,17]],"date-time":"2007-01-17T00:03:14Z","timestamp":1168992194000},"page":"171-176","source":"Crossref","is-referenced-by-count":85,"title":["Treating Homeless Opioid Dependent Patients with Buprenorphine in an Office-Based Setting"],"prefix":"10.1007","volume":"22","author":[{"given":"Daniel P.","family":"Alford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colleen T.","family":"LaBelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica M.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James J.","family":"O\u2019Connell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carole A.","family":"Hohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debbie M.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey H.","family":"Samet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,1,17]]},"reference":[{"key":"23_CR1","unstructured":"US Department of Health and Human Services. Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2004 National Survey on Drug Use & Health. Available at http:\/\/oas.samhsa.gov\/NSDUH\/2k4NSDUH\/2k4results\/2k4results.htm#ch2 . Accessed July 11, 2006."},{"key":"23_CR2","unstructured":"US Department of Health and Human Services. Substance Abuse and Mental Health Services Administration (SAMHSA). The DASIS Report: Non-Heroin Opiate Admissions, 2003. Results from the Drug and Alcohol Services Information System (DASIS). 2003. Available at http:\/\/oas.samhsa.gov\/2k6\/opiatesTX\/opiatesTX.cfm . Accessed July 11, 2006."},{"key":"23_CR3","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1001\/jama.280.22.1936","volume":"280","author":"National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction","year":"1998","unstructured":"National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. Effective medical treatment of opiate addiction. JAMA. 1998;280:1936\u201343.","journal-title":"JAMA"},{"key":"23_CR4","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1001\/jama.1992.03480200058024","volume":"267","author":"RE Johnson","year":"1992","unstructured":"Johnson RE, Jaffe JH, and Fudala PJ. A controlled trial of buprenorphine treatment for opioid dependence. JAMA. 1992;267:2750\u201355.","journal-title":"JAMA"},{"key":"23_CR5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/archpsyc.1996.01830050035005","volume":"53","author":"W Ling","year":"1996","unstructured":"Ling W, Wesson DR, Charuvastra C, and Klett CJ. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Arch Gen Psychiatry. 1996;53:401\u20137.","journal-title":"Arch Gen Psychiatry"},{"key":"23_CR6","doi-asserted-by":"crossref","unstructured":"Ball JC and Ross A. The Effectiveness of Methadone Maintenance Treatment. New York, NY: Springer\u2014Berlin Heidelberg New York; 1991.","DOI":"10.1007\/978-1-4613-9089-3"},{"key":"23_CR7","first-page":"347","volume":"67","author":"H Joseph","year":"2000","unstructured":"Joseph H, Stancliff S, and Langrod J. Methadone maintenance treatment (MMT): a review of historical and clinical issues. Mt Sinai J Med. 2000;67:347\u201364.","journal-title":"Mt Sinai J Med"},{"key":"23_CR8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.7326\/0003-4819-133-1-200007040-00008","volume":"133","author":"PG O\u2019Connor","year":"2000","unstructured":"O\u2019Connor PG and Fiellin DA. Pharmacologic treatment of heroin-dependent patients. Ann Intern Med. 2000;133:40\u201354.","journal-title":"Ann Intern Med"},{"key":"23_CR9","unstructured":"Institute of Medicine. Federal regulation of methadone treatment. Washington, DC: National Academy of Medicine; 1995."},{"key":"23_CR10","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJM200011023431802","volume":"343","author":"RE Johnson","year":"2000","unstructured":"Johnson RE, Chutuape MA, Strain EC, Walsh SL, Stitzer ML, and Bigelow GE. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. N Engl J Med. 2000;343:1290\u20137.","journal-title":"N Engl J Med"},{"key":"23_CR11","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJMoa022164","volume":"349","author":"PJ Fudala","year":"2003","unstructured":"Fudala PJ, Bridge TP, Herbert S, et al. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. N Engl J Med. 2003;349:949\u201358.","journal-title":"N Engl J Med"},{"key":"23_CR12","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0140-6736(03)12600-1","volume":"361","author":"J Kakko","year":"2003","unstructured":"Kakko J, Svanborg KD, Kreek MJ, and Heilig M. 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial. Lancet. 2003;361:662\u20138.","journal-title":"Lancet"},{"key":"23_CR13","doi-asserted-by":"crossref","first-page":"688","DOI":"10.7326\/0003-4819-137-8-200210150-00014","volume":"137","author":"DA Fiellin","year":"2002","unstructured":"Fiellin DA and O\u2019Connor PG. New federal initiatives to enhance the medical treatment of opioid dependence. Ann Intern Med. 2002;137:688\u201392.","journal-title":"Ann Intern Med"},{"key":"23_CR14","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1525-1497.2005.0228.x","volume":"20","author":"MD Stein","year":"2005","unstructured":"Stein MD, Cioe P, and Friedmann PD. Buprenorphine retention in primary care. J Gen Intern Med. 2005;20:1038\u201341.","journal-title":"J Gen Intern Med"},{"issue":"suppl","key":"23_CR15","first-page":"103","volume":"19","author":"DP Alford","year":"2004","unstructured":"Alford DP, Saitz R, LaBelle CT, and Samet JH. Buprenorphine initiation and maintenance in primary care: a successful interdisciplinary approach. J Gen Intern Med. 2004;19(suppl):103.","journal-title":"J Gen Intern Med"},{"key":"23_CR16","unstructured":"Center for Substance Abuse Treatment. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction, Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04-3939. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2004."},{"key":"23_CR17","unstructured":"Center for Substance Abuse Treatment. Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs, Treatment Improvement Protocol (TIP) Series 43. DHHS Publication No. (SMA) 05-4048. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2005."},{"key":"23_CR18","doi-asserted-by":"crossref","unstructured":"Burt MR, Aron LY, Douglas T, Valente J, Lee E, and Iwen B. Homelessness: programs and the people they serve. Technical report of findings of the National Survey of Homeless Assistance Providers and Clients. 1999. Interagency Council on the Homeless.","DOI":"10.1037\/e726182011-001"},{"key":"23_CR19","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1037\/0003-066X.46.11.1115","volume":"46","author":"PJ Fischer","year":"1991","unstructured":"Fischer PJ and Breakey WR. The epidemiology of alcohol, drug, and mental disorders among homeless persons. Am J Psychol. 1991;46:1115\u201328.","journal-title":"Am J Psychol"},{"key":"23_CR20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/009145099502200203","volume":"22","author":"GJ Stahler","year":"1995","unstructured":"Stahler GJ and Cohen E. Homelessness and substance abuse in the 1990s. Contemp Drug Probl. 1995;22:169\u201392.","journal-title":"Contemp Drug Probl."},{"key":"23_CR21","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00005650-199903000-00010","volume":"37","author":"P Koegel","year":"1999","unstructured":"Koegel P, Sullivan G, Burnam A, Morton SC, and Wenzel S. Utilization of mental health and substance abuse services among homeless adults in Los Angeles. Med Care. 1999;37:306\u201317.","journal-title":"Med Care"},{"key":"23_CR22","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1056\/NEJM199408043310506","volume":"331","author":"JR Hibbs","year":"1994","unstructured":"Hibbs JR, Benner L, Klugman L, et al. Mortality in a cohort of homeless adults in Philadelphia. N Engl J Med. 1994;331:304\u20139.","journal-title":"N Engl J Med"},{"key":"23_CR23","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1001\/archinte.158.13.1454","volume":"158","author":"SW Hwang","year":"1998","unstructured":"Hwang SW, Lebow JM, Bierer MF, O\u2019Connell JJ, Orav J, and Brennan TA. Risk factors for death in homeless adults in Boston. Arch Int Med. 1998;158:1454\u201360.","journal-title":"Arch Int Med"},{"key":"23_CR24","volume-title":"Homelessness and health","author":"JD Wright","year":"1987","unstructured":"Wright JD and Weber E. Homelessness and health. New York, NY: McGraw-Hill, Inc; 1987."},{"key":"23_CR25","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.2105\/AJPH.91.11.1842","volume":"91","author":"KH Seal","year":"2001","unstructured":"Seal KH, Kral AH, Gee L, et al. Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998\u20131999. Am J Public Health. 2001;91:1842\u20136.","journal-title":"Am J Public Health"},{"key":"23_CR26","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1081\/JA-120017380","volume":"38","author":"T Blanchon","year":"2003","unstructured":"Blanchon T, Boissonnas A, Vareseon I, and Vidal-Trecan G. Homelessness and high-dosage buprenorphine misuse. Subst Use Misuse. 2003;38:429\u201342.","journal-title":"Subst Use Misuse"},{"key":"23_CR27","first-page":"204","volume-title":"Under the safety net: The health and social welfare of the homeless in the United States","author":"L Thomas","year":"1990","unstructured":"Thomas L, Kelly M, and Cousineau M. Alcoholism and substance abuse. In: Brickner PW, Scharer LK, Conanan BA, Savarese M, and Scanlan BC, eds. Under the safety net: The health and social welfare of the homeless in the United States. New York, NY: W.W. Norton & Co.; 1990;204\u201314."},{"key":"23_CR28","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/BF02344031","volume":"77","author":"JY Song","year":"2000","unstructured":"Song JY, Safaeian M, Strathdee SA, Vlahov D, and Celentano DD. The prevalence of homelessness among injection drug users with and without HIV infection. J Urban Health. 2000;77:678\u201387.","journal-title":"J Urban Health"},{"key":"23_CR29","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jsat.2004.03.002","volume":"26","author":"M Galanter","year":"2004","unstructured":"Galanter M, Dermatis H, Glickman L, et al. Network therapy: decreased secondary opioid use during buprenorphine maintenance. J Subst Abuse Treat. 2004;26:313\u20138.","journal-title":"J Subst Abuse Treat"},{"key":"23_CR30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0740-5472(03)00026-6","volume":"24","author":"SG Kertesz","year":"2003","unstructured":"Kertesz SG, Horton NJ, Friedmann PD, Saitz R, and Samet JH. Slowing the revolving door: stabilization programs reduce homeless persons\u2019 substance use after detoxification. J Subst Abuse Treat. 2003;24:197\u2013207.","journal-title":"J Subst Abuse Treat"},{"key":"23_CR31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0376-8716(96)01286-0","volume":"43","author":"JB Milby","year":"1996","unstructured":"Milby JB, Schumacher JE, Raczynski JM, et al. Sufficient conditions for effective treatment of substance abusing homeless persons. Drug Alcohol Depend. 1996;43:39\u201347.","journal-title":"Drug Alcohol Depend"},{"key":"23_CR32","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1097\/00002030-200009080-00020","volume":"14","author":"NG Shah","year":"2000","unstructured":"Shah NG, Celentano DD, Vlahov D, et al. Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus. AIDS. 2000;14:2035\u201343.","journal-title":"AIDS"},{"key":"23_CR33","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3109\/14659899909053018","volume":"4","author":"W Mistral","year":"1999","unstructured":"Mistral W and Velleman R. Are practice nurses an underused resource for managing patients having problems with illicit drugs? J Subst Use. 1999;4:82\u20137.","journal-title":"J Subst Use"},{"key":"23_CR34","unstructured":"SAS Institute Inc. SAS\/STAT Software: Changes and Enhancements, Release 8.2. Cary, NC: SAS Institute Inc.; 2001."},{"key":"23_CR35","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1377\/hlthaff.21.3.80","volume":"21","author":"DM Berwick","year":"2002","unstructured":"Berwick DM. A user\u2019s manual for the IOM\u2019s \u2018quality chasm\u2019 report. Health Aff. 2002;21:80\u201390.","journal-title":"Health Aff"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-006-0023-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11606-006-0023-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-006-0023-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T17:32:15Z","timestamp":1559410335000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11606-006-0023-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,17]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["23"],"URL":"https:\/\/doi.org\/10.1007\/s11606-006-0023-1","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,17]]}}}